Effects of proteasome and calpain inhibitors on the structural reorganization and proliferation of vascular smooth muscle cells in primary culture

Laboratory Investigation

Volumn 79, Issue 9, 1999, Pages 1077-1088

  Thyberg, Johan ^a   Blomgren, Karin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALPASTATIN; LACTACYSTIN; PROTEASOME INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CELL DIVISION; CELL PROLIFERATION; CELL STRUCTURE; ELECTRON MICROSCOPY; IMMUNOGOLD STAINING; MORPHOLOGY; MUSCLE CONTRACTILITY; MYOFILAMENT; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; RAT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

ACTINS; ADENOSINE TRIPHOSPHATASES; ANIMALS; CALPAIN; CELL DIVISION; CYSTEINE PROTEINASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MULTIENZYME COMPLEXES; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; UBIQUITINS;

EID: 0032875022     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bercovich B, Stancovski I, Mayer A, Blumenfeld N, Laszlo A, Schwartz AL, and Ciechanover A (1997). Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70. J Biol Chem 272: 9002-9010.
2. Campbell JH, Kocher O, Skalli O, Gabbiani G, and Campbell GR (1989). Cytodifferentiation and expression of α-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells: Correlation with cell density and proliferative state. Arteriosclerosis 9:633-643.
3. Carafoli E and Molinari M (1989). Calpain - a protease in search of a function. Biochem Biophys Res Commun 247: 193-203.
4. Chamley-Campbell JH, Campbell GR, and Ross R (1981). Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 89:379-383.
5. Chaponnier C, Kocher O, and Gabbiani G (1990). Modulation of gelsolin content in rat aortic smooth muscle cells during development, experimental intimai thickening and culture. Eur J Biochem 190:559-565.
6. Cuervo AM and Dice JF (1998). Lysosomes, a meeting point of proteins, chaperones, and proteases. J Mol Med 76:6-12.
7. Fenteany G and Schreiber SL (1998). Lactacystin, proteasome function, and cell fate. J Biol Chem 273:8545-8548.
8. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, and Schreiber SL (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-731.
9. Furuno K, Goodman MN, and Goldberg AL (1990). Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem 265:8550-8557.
10. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, and Weber K (1984). Actin expression in smooth muscle cells of rat aortic intimai thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest 73:148-152.
11. Gonen H, Stancovski I, Shkedy D, Hadari T, Bercovich B, Bengal E, Mesilati S, Abu-Hatoum O, Schwartz AL, and Ciechanover A (1996). Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3: Targeting of protein substrates via multiple and distinct recognition signals and conjugating enzymes. J Biol Chem 271:302-310.
12. Hedin U and Thyberg J (1987). Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. Differentiation 33:239-246.
13. Hedin U, Bottger BA, Forsberg E, Johansson S, and Thyberg J (1988). Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 107:307-319.
14. Hedin U, Bottger BA, Luthman J, Johansson S, and Thyberg J (1989). A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev Biol 133:489-501.
15. Hershko A and Ciechanover A (1998). The ubiquitin system. Annu Rev Biochem 67:425-479.
16. Huttenlocher A, Palecek SP, Lu Q, Zhang W, Mellgren RL, Lauffenburger DA, Ginsberg MH, and Horwitz AF (1997). Regulation of cell migration by the calcium-dependent protease calpain. J Biol Chem 272:32719-32722.
17. King RW, Deshaies RJ, Peters J-M, and Kirschner MW (1996). How proteolysis drives the cell cycle. Science 274: 1652-1659.
18. Lee DH and Goldberg AL (1998). Proteasome inhibitors: Valuable new tools for cell biologists. Trends Cell Biol 8:397-403.
19. Owens GK (1995). Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487-517.
20. Owens GK (1996). Role of alterations in the differentiated state of vascular smooth muscle cells in atherogenesis. In: Fuster V, Ross R, and Topol EJ, editors. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 401-420.
21. Owens GK, Loeb A, Gordon D, and Thompson MM (1986). Expression of smooth muscle-specific α-isoactin in cultured vascular smooth muscle cells: Relationship between growth and cytodifferentiation. J Cell Biol 102:343-352.
22. Pagano M (1997). Cell cycle regulation by the ubiquitin pathway. FASEB J 11:1067-1075.
23. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes C, Fiacco KA, Mier JW, Maki M, and Herman IM (1998). Calpain regulates actin remodeling during cell spreading. J Cell Biol 141:647-662.
24. Rivett AJ (1998). Intracellular distribution of proteasomes. Curr Opin Immunol 10:110-114.
25. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, and Goldberg AL (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
26. Ross R and Fuster V (1996). The pathogenesis of atherosclerosis. In: Fuster V, Ross R, and Topol EJ, editors. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 441-460.
27. Salvesen GS and Dixit VM (1997). Caspases: Intracellular signaling by proteolysis. Cell 91:443-446.
28. Sasaki T, Kishi M, Saito M, Tanaka T, Higuchi N, Kominami E, Katunuma N, and Murachi T (1990). Inhibitory effect of diand tripeptidyl aldehydes on calpains and cathepsins. J Enzym Inhib 3:195-201.
29. Schwartz SM and Reidy MA (1996). Restenosis: An assessment of factors important in arterial occlusion. In: Fuster V, Ross R, and Topol EJ, editors. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers, 701-714.
30. Solomon V and Goldberg AL (1996). Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271:26690-26697.
31. Sorimachi H, Ishiura S, and Suzuki K (1997). Structure and physiological functions of calpains. Biochem J 328:721-732.
32. Taylor RG, Tassy C, Briand M, Robert N, Briand Y, and Ouali A (1995). Proteolytic activity of proteasome on myofibrillar structures. Mol Biol Rep 21:71-73.
33. Thyberg J (1996). Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169:183-265.
34. Thyberg J (1998). Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol Histopathol 13:871-891.
35. Thyberg J and Blomgren K (1990). Phenotype modulation in primary cultures of rat aortic smooth muscle cells: Effects of drugs that interfere with the functions of the vacuolar system and the cytoskeleton. Virchows Arch B Cell Pathol 59:1-10.
36. Thyberg J, Hedin U, and Bottger BA (1990). Attachment substrates for smooth muscle cells. In: Piper HM, editor. Cell culture techniques in heart and vessel research. Berlin: Springer-Verlag, 315-333.
37. Thyberg J, Palmberg L, Nilsson J, Ksiazek T, and Sjölund M (1983). Phenotype modulation in primary cultures of arterial smooth muscle cells: On the role of platelet-derived growth factor. Differentiation 25:156-167.
38. Thyberg J, Roy J, Tran PK, Blomgren K, Dumitrescu A, and Hedin U (1997). Expression of caveolae on the surface of rat arterial smooth muscle cells is dependent on the phenotypic state of the cells. Lab Invest 77:93-101.
39. Varshavsky A (1997). The ubiquitin system. Trends Biochem Sci 22:383-387.
40. Villa P, Kaufmann SH, and Earnshaw WC (1997). Caspases and caspase inhibitors. Trends Biochem Sci 22:388-393.
41. Weibel ER (1969). Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 26:235-302.
42. Welch MD, Mallavarapu A, Rosenblatt J, and Mitchison TJ (1997). Actin dynamics in vivo. Curr Opin Cell Biol 9:54-61.